Waltregny D - Search Results

1

Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis.

Conrotto P, Roesli C, Rybak J, Kischel P, Waltregny D, Neri D, Castronovo V. Conrotto P, et al. Among authors: waltregny d. Int J Cancer. 2008 Dec 15;123(12):2856-64. doi: 10.1002/ijc.23861. Int J Cancer. 2008. PMID: 18798264

2

Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting.

Kischel P, Waltregny D, Dumont B, Turtoi A, Greffe Y, Kirsch S, De Pauw E, Castronovo V. Kischel P, et al. Among authors: waltregny d. Int J Cancer. 2010 Feb 1;126(3):640-50. doi: 10.1002/ijc.24812. Int J Cancer. 2010. PMID: 19662655

3

A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer.

Castronovo V, Waltregny D, Kischel P, Roesli C, Elia G, Rybak JN, Neri D. Castronovo V, et al. Among authors: waltregny d. Mol Cell Proteomics. 2006 Nov;5(11):2083-91. doi: 10.1074/mcp.M600164-MCP200. Epub 2006 Jul 21. Mol Cell Proteomics. 2006. PMID: 16861259 Free article.

4

Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method.

Castronovo V, Kischel P, Guillonneau F, de Leval L, Deféchereux T, De Pauw E, Neri D, Waltregny D. Castronovo V, et al. Among authors: waltregny d. Proteomics. 2007 Apr;7(8):1188-96. doi: 10.1002/pmic.200600888. Proteomics. 2007. PMID: 17372937

5

Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.

Kischel P, Waltregny D, Castronovo V. Kischel P, et al. Among authors: waltregny d. Expert Rev Proteomics. 2007 Dec;4(6):727-39. doi: 10.1586/14789450.4.6.727. Expert Rev Proteomics. 2007. PMID: 18067412 Review.

6

Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness.

Chaplet M, Waltregny D, Detry C, Fisher LW, Castronovo V, Bellahcène A. Chaplet M, et al. Among authors: waltregny d. Int J Cancer. 2006 Feb 15;118(4):850-6. doi: 10.1002/ijc.21442. Int J Cancer. 2006. PMID: 16108038

7

Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma.

Kischel P, Waltregny D, Greffe Y, Mazzucchelli G, De Pauw E, de Leval L, Castronovo V. Kischel P, et al. Among authors: waltregny d. Proteome Sci. 2011 Oct 5;9(1):63. doi: 10.1186/1477-5956-9-63. Proteome Sci. 2011. PMID: 21975223 Free PMC article.

8

Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression.

van den Brûle FA, Waltregny D, Liu FT, Castronovo V. van den Brûle FA, et al. Among authors: waltregny d. Int J Cancer. 2000 Jul 20;89(4):361-7. doi: 10.1002/1097-0215(20000720)89:4<361::aid-ijc8>3.0.co;2-u. Int J Cancer. 2000. PMID: 10956411

9

Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation.

Waltregny D, Alami Y, Clausse N, de Leval J, Castronovo V. Waltregny D, et al. Prostate. 2002 Feb 15;50(3):162-9. doi: 10.1002/pros.10045. Prostate. 2002. PMID: 11813208

10

[Targeted therapy: toward a clean and effective war against cancer].

Castronovo V, Waltregny D, Detry O, Coimbra Marques C, De Roover A, Honoré P, De Pauw E, Turtoi A. Castronovo V, et al. Among authors: waltregny d. Rev Med Liege. 2009;64 Spec No:20-3. Rev Med Liege. 2009. PMID: 20085011 Free article. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters